Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications

View Sample PDF

Author(s): Arti Patel (University of South Florida, USA)and Yashwant V. Pathak (University of South Florida, USA)
Copyright: 2017
Pages: 9
Source title: Emerging Applications, Perspectives, and Discoveries in Cardiovascular Research
Source Author(s)/Editor(s): Ashim Malhotra (Pacific University, USA)and Shivani Soni (California State University, Fullerton, USA & Chapman University, USA & Alabama State University, USA)
DOI: 10.4018/978-1-5225-2092-4.ch014

Keywords: Cardiovascular Medicine / Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare

Purchase

View Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications on the publisher's website for pricing and purchasing information.

Abstract

Nanomedicine has vastly improved the treatment and diagnosis of many cardiovascular conditions such as atherosclerosis, myocardial ischemia, myocardial infarction, restenosis, and thrombosis. A few nanoparticle drug delivery systems that are currently being tested and used in clinical trials include lipid-based drug delivery, controlled drug release, and specific targeting. The chapter describes the various drug delivery methods, the various nanoparticles, and their application on specific cardiovascular conditions. This chapter compiles examples of specific clinical trials that are being conducted, using nanoparticles for therapy of cardiovascular conditions.

The IRMA Community

Research IRM

Nanoparticle-Based Drug Delivery Systems for Cardiovascular Applications

Purchase

Abstract

Related Content

IRMA Sponsors